Article

Programs & Initiatives

How One Woman’s Feeling of Helplessness Launched an Initiative to Hire Refugees

The images, unfortunately, have been too common for far too long: people young and old, refugees whose lives have been upended by forces beyond their control, fleeing their homes for safety. Watching it as it unfolds can make someone feel powerless. But what can one person do to make a difference? That was the question Mona Babury asked herself in August 2021 when the Taliban seized control in Afghanistan. From her home near New York City, as she watched footage of Afghan refugees, the trauma...

Meet The People of PGS: Terrari

Through the “People of PGS” series, we spotlight the names and faces behind the great work we do in PGS.  Next up is Terrari, a Continuous Improvement Specialist in Sanford, North Carolina, and co-lead of the site’s Global Black Community Colleague Resource Group chapter.Over the course of his six years at Pfizer, Terrari has directly impacted PGS’s ability to help patients. Whether it was working on the start-up and quick transition to commercial production of one of Pfizer’s rare disease...

Living & Wellbeing

Understanding Six Types of Vaccine Technologies

Ever since the first vaccine was developed in 1796 to treat smallpox,1 several different methods have been created to develop successful vaccines. Today, those methods, known as vaccine technologies, are more advanced and use the latest technology to help protect the world from preventable diseases.2Depending on the pathogen (a bacteria or virus) that is being targeted, different vaccine technologies are used to generate an effective vaccine. Just like there are multiple ways to develop a...

Living & Wellbeing

Finding Breakthroughs in Sickle Cell Disease: Patients and Advocates Lead the Way

In most types of clinical research, a large number of patients participate in studies that explore an experimental treatment or approach. This decades-old process is how some of the most impactful, and even lifesaving therapies have come to be, from cancer drugs to COVID-19 vaccines.1 But what happens when scientists need to study a rare disease, one that doesn’t affect a high percentage of people? And what if those who are affected don’t participate because of social disparities...

Pfizer Statement on Results of Third Annual Pay Equity Study Among Colleagues Worldwide

NEW YORK, N.Y., February 22, 2022 – Pfizer Inc. (NYSE:PFE) stated today that, for the third year in a row, a recognized compensation expert confirmed equitable pay practices for employees at Pfizer.The study assessed pay for gender worldwide and for minorities in the United States based on compensation data, including base pay, merit increases and bonuses. The study measured the difference between similar groups of employees when adjusting for factors such as role, grade, job level, experience...

Reasons To Reject Massachusetts’ Misguided Drug Pricing Bill

Massachusetts state legislators are considering a dangerous bill that could stifle innovation, limit patients’ access to medicines, and interfere with market competition. The bill would grant the state government broad authority to arbitrarily set the prices of medications, which could threaten the biopharmaceutical industry’s contributions to the state’s economy.We all share the goal of ensuring that life-saving medicines are accessible and affordable for all, but this misguided bill is not the...

How Pfizer is fostering meaningful growth for every colleague, everywhere

Redefining Career Growth at PfizerAt Pfizer, we’re transforming and redefining ‘growth’ for our colleagues. To live and deliver on our purpose: breakthroughs that change patients’ lives, we need to continually grow ourselves and those around us. Doing this – while thinking big and pursuing bold goals – will help us to bring medicines and vaccines forward that can radically alter the course of a disease. We now see growth as a part of our DNA: We grow every day. In practice, this means promoting...

Insurers and middlemen profiting more from prescription drugs

Vaccines continue to help keep millions safe despite an ever-changing adversary, and there is new hope in the form of treatments that may prevent the most severe outcomes when infections do occur. While science drives us forward, we are also focused on the common goal of finding ways to lower healthcare costs for patients.As we all look for policies to achieve that goal, it’s imperative to look at all the cost drivers in the prescription drug system, and new data demonstrates for the first time...

Reasons to Reject the Dangerous Medicare Pricing Proposal

Making sure that medicines are accessible and affordable for patients is a goal we all share. But policymakers are considering a dangerous Medicare reform policy that could threaten the future of groundbreaking cures.The policy would allow government “negotiations” on the price of medicines for Medicare, and would give government a greater hand in dictating prices, rather than the current system that promotes competition. Moreover, this misguided policy would repeal a key provision of the...

One Year Later: Pfizer Update on Progress of Humanitarian Assistance Program

In November 2016, Pfizer Inc. announced a major expansion of its humanitarian assistance program enabling broader access to its pneumococcal conjugate vaccine (PCV) in humanitarian emergency settings. During the year since, the Company has made important progress on a number of fronts to support access. In January 2017, our multi dose vial (MDV) of PCV became available in the world's poorest countries through our partnership with Gavi, the Vaccine Alliance. It has also been used to vaccinate...

Supporting Refugee Communities In Africa

Photo Credit: International Rescue CommitteeToday the Pfizer Foundation* is pleased to announce new funding for three important humanitarian organizations to specifically support their work with refugees and internally displaced people. The grant recipients include the International Medical Corps., the International Rescue Committee (IRC), and World Vision. The grants will support activities in acute refugee settings in areas that have some of the greatest need."The ongoing refugee crisis is one...

Inroads X Pfizer – A Progressive Partnership

Innovation isn’t easy. Otherwise everyone could do it.It takes many talented people putting their heads together to find inventive ways around some of the world’s biggest and toughest challenges. But, on top of being talented, everyone needs to be talented in different ways.If you send a group of people with similar backgrounds and experiences a challenge, chances are they’d approach it in the same way. But that is not how innovation happens. You need different people. From different backgrounds...